These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34055746)

  • 1. The First Insight Into the Supramolecular System of
    Bojarska J; New R; Borowiecki P; Remko M; Breza M; Madura ID; Fruziński A; Pietrzak A; Wolf WM
    Front Chem; 2021; 9():679776. PubMed ID: 34055746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
    Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
    Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity.
    Coons T; Hanson S; Bitonti AJ; McCann PP; Ullman B
    Mol Biochem Parasitol; 1990 Feb; 39(1):77-89. PubMed ID: 2154691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
    Merali S; Clarkson AB
    Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Supramolecular Approach to Structure-Based Design with A Focus on Synthons Hierarchy in Ornithine-Derived Ligands: Review, Synthesis, Experimental and in Silico Studies.
    Bojarska J; Remko M; Breza M; Madura ID; Kaczmarek K; Zabrocki J; Wolf WM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32138329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
    Selamnia M; Mayeur C; Robert V; Blachier F
    Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine.
    Grishin NV; Osterman AL; Brooks HB; Phillips MA; Goldsmith EJ
    Biochemistry; 1999 Nov; 38(46):15174-84. PubMed ID: 10563800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
    Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
    Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insight into DFMO resistant ornithine decarboxylase from Entamoeba histolytica: an inkling to adaptive evolution.
    Preeti ; Tapas S; Kumar P; Madhubala R; Tomar S
    PLoS One; 2013; 8(1):e53397. PubMed ID: 23326423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases.
    LoGiudice N; Le L; Abuan I; Leizorek Y; Roberts SC
    Med Sci (Basel); 2018 Feb; 6(1):. PubMed ID: 29419804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative proteomic screen to identify potential drug resistance mechanism in α-difluoromethylornithine (DFMO) resistant Leishmania donovani.
    Singh AK; Roberts S; Ullman B; Madhubala R
    J Proteomics; 2014 May; 102():44-59. PubMed ID: 24631822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of polyamine biosynthesis in Crithidia fasciculata by D,L-alpha-difluoromethylornithine and D,L-alpha-difluoromethylarginine.
    Hunter KJ; Strobos CA; Fairlamb AH
    Mol Biochem Parasitol; 1991 May; 46(1):35-43. PubMed ID: 1852175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening of natural inhibitors targeting ornithine decarboxylase with pharmacophore scaffolding of DFMO and validation by molecular dynamics simulation studies.
    Sivashanmugam M; K N S; V U
    J Biomol Struct Dyn; 2019 Feb; 37(3):766-780. PubMed ID: 29436980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
    Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
    Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine biosynthetic pathways and their relation with the cold tolerance of maize (
    Gao C; Sheteiwy MS; Han J; Dong Z; Pan R; Guan Y; Alhaj Hamoud Y; Hu J
    Plant Signal Behav; 2020 Nov; 15(11):1807722. PubMed ID: 32799616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.
    Love RR; Carbone PP; Verma AK; Gilmore D; Carey P; Tutsch KD; Pomplun M; Wilding G
    J Natl Cancer Inst; 1993 May; 85(9):732-7. PubMed ID: 8478959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.
    Bellofatto V; Fairlamb AH; Henderson GB; Cross GA
    Mol Biochem Parasitol; 1987 Oct; 25(3):227-38. PubMed ID: 3122042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
    Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
    Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
    Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
    Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
    PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.